Fig. 4.

Effect of history of NIHF on the change over time in height in patients with MPS VII. Height was assessed in male (A) and female (B) patients with MPS VII aged ≤36 months and all ages versus the height percentiles of the healthy population using the Centers for Disease Control and National Center for Health Statistics Clinical Growth Chart. Each red dot represents a single height measurement in a patient with a history of NIHF; each blue dot represents a single height measurement in a patient without a history of NIHF. MPS, mucopolysaccharidosis; NIHF, non-immune hydrops fetalis.